Year-over-year earnings per share growth for the last twelve months: ALX Oncology (ALXO)

alxoncology.com (ALXO) - corporate logo

ALX Oncology Holdings (ALXO) relies on cash reserves, as the absence of revenue results in negative cash flow. The quarterly EPS growth efficiency metric reflects market dynamics, with the indicator standing at 61.90. The integrity of biologics is ensured by strict climate control during delivery. The proprietary protein evorpacept creates a pre-commercial moat, the success of which depends on the outcomes of late-stage clinical trials.

alxoncology.com (ALXO) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for alxoncology.com (ALXO)

- company stock exchange capitalization indicators:
Comprehensive company analysis:alxoncology.com, ALXO
Manufactured product of ALX Oncology Holdings

This indicator captures the dynamics of quarterly earnings per share (EPS), allowing for an assessment of the growth or contraction of the business's operational efficiency. By analyzing the quarterly EPS trajectory, an investor can correlate the financial stability of ALX Oncology Holdings (ALXO) with the absence of current revenue, where negative cash flow renders this metric a critical signal regarding capital expenditure on clinical trials.

Competitors of ALX Oncology Holdings

IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months januxrx.com|Year-over-year net earnings per share growth for the last 12 months arcusbio.com (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc (ZYME)|Year-over-year net earnings per share growth for the last 12 months Tango Pharma TNGX|Iovance Biotherapeutics Inc - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics Biotechnologies IMTX|XNCR - Year-over-year earnings per share growth for the last twelve months|CMPX (compasstherapeutics.com) - Year-over-year earnings per share growth for the last 12 months|Replimune Inc. (REPL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Lyell Immunopharma Inc (LYEL)|Year-over-year net earnings per share growth for the last 12 months IPHA|PYXS - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months CGEN (Compugen Ltd.)|Year-over-year earnings per share growth rate for the last twelve months IOBT|Quarterly EPS earnings growth STRO (Sutro Biopharma)|Year-over-year earnings per one share growth for the last 12 months INKT|Werewolf - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Immix Biopharma|CUE: Quarterly EPS earnings growth|PDS Biotech - Year-over-year earnings per one share growth for the last 12 months|SONN (Sonnet BioTherapeutics Holdings Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth MAIA Biotech|Year-over-year earnings per share growth for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Year-over-year net earnings per share trend for the last twelve months|NextCure Inc - Year-over-year net earnings per share growth for the last 12 months|Leap Therapeutics, Inc. (LPTX) - Earnings per share growth in annualized terms for the last twelve months|Intensity Therapeutics Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months senseibio.com SNSE|TOVX: Quarterly EPS earnings growth|Gritstone bio Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KA|Year-over-year earnings per share growth for the last 12 months NEXI (NexImmune, Inc.)|Year-over-year earnings per share growth for the last twelve months Turnstone Biologics Corporation (TSBX)|Year-over-year net earnings per share growth for the last 12 months Vaccinex VCNX|Year-over-year earnings per share growth for the last twelve months harpoontx.com HARP